Volver a Agenda
Session 20: Preparing for CMC Meetings with FDA
Session Chair(s)
Albert S. Yehaskel, MBA
President and CEO
Refuah Global Pharmaceutical Development, Inc., United States
- Strategies for Meeting with FDA
- Planning and Important Documents for a CM&C Meeting
- Meeting Request Letter
- The Briefing Document
- Regulatory Mechanism for an FDA Meeting
- Preparing for the Meeting, Rehearsals; During the Meeting
- Types of Meetings Encountered During Drug Development
¿Tiene una cuenta?